MSc, MD Nong Ngoc Son

MSc, MD Nong Ngoc Son

MSc, MD Nong Ngoc Son

Languages spoken: Vietnamese

About

MD. Nong Ngoc Son has many years’ experience in treatment for patients with cancer, especially in chemotherapy, metastasized late stage and end-stage cancer. He was trained domestically and internationally such as Harvard University of Medicine, Japan Institute of Biotherapy before being Chemotherapist and Palliative Doctor at Vinmec Central Park International Hospital as present.

Roles

Chemotherapist and Palliative Doctor

Specialties

  • Oncology- Radiotherapy

Workplace


Services

  • Diagnosis and treatment plan for lung, breast, colon, duodenal and gastric cancer
  • Chemotherapy and palliative care for its side effect
  • Palliative care for patient at late stage and end stage
  • Immunotherapy and biotherapy.

  • General Practitioner at Ho Chi Minh City University of Medicine and Pharmacy
  • Resident Physician in Oncology at Ho Chi Minh City University of Medicine and Pharmacy
  • Master Degree in Oncology at Ho Chi Minh City University of Medicine and Pharmacy
  • First Degree Specialist in Oncology at Ho Chi Minh City University of Medicine and Pharmacy
  • 2013: Basic training in palliative care by Harvard University for Oncologist in Ho Chi Minh City
  • 2014: Certificate of early screening and detection of cancer at Ho Chi Minh City University of Medicine and Pharmacy
  • 2015: Training program for lecturer in Palliative Care which is cooperated with Harvard University of Medicine and Ho Chi Minh City Hospital of Oncology
  • 2018: Trained in autologous immune enhancement therapy at Tokyo Clinic, Japan Institute of Biotherapy
  • 2018: Trained in coordinated multimodal therapy for cancer at Sun Yat Set Koo Foundation Cancer Center, Taiwan

  • Internist at District 2 Hospital, Ho Chi Minh City
  • Residency Doctor in Oncology at Ho Chi Minh City Hospital of Oncology
  • Oncology Department – Vinmec Central Park International Hospital

  • ‘TSH and papillary thyroid cancer’ – the 10th International Conference of Cancer, Seoul, Korea, 2012
  • ‘Prognosis of life time for patients with terminal cancer HCMC Conference of Cancer Prevention, 2015.